While American investors have spent the last decade celebrating the Magnificent Seven and paying premium multiples for U.S. growth, a quiet category of overseas stocks has been compounding in the shadows. The Fidelity International Value Factor ETF (NYSEARCA:FIVA) is the kind of fund that never trends on social media, never gets a sell-side cult following, and probably never will. That is exactly why it deserves a look right now.
The setup is simple. The S&P 500 trades near historic valuation highs while developed-markets value stocks in Europe, Japan, and Canada still trade at single-digit multiples in some sectors. FIVA is the anti-hype ETF. It screens developed markets outside the U.S. for the cheapest large- and mid-cap names. Boring, yes. Mispriced, possibly.
What FIVA Is Actually Buying
FIVA tracks the Fidelity International Value Factor Index, a rules-based screen that ranks stocks within each sector using value measures like free cash flow yield, earnings yield, and book-to-price. The fund holds roughly 100 names across developed markets ex-U.S., with the heaviest country weights in Japan, the United Kingdom, Canada, France, and Switzerland. The expense ratio runs 0.18%, with assets under management at roughly $534 million. Small fund, low cost, narrow mandate.
The return engine is straightforward. FIVA owns shares of profitable foreign companies that trade at depressed multiples relative to their cash flows. You make money two ways. First, those businesses keep generating earnings and paying dividends, which compound regardless of whether the market re-rates them. Second, if the multi-decade valuation gap between U.S. and international stocks ever narrows, the price-to-earnings expansion is the kicker. The within-sector ranking matters because it prevents the fund from becoming a pure bet on cheap European banks or Japanese carmakers. You get value exposure without an accidental sector wager.
The Performance Reality Check
For most of FIVA’s life since its January 2018 inception, the answer to “does international value deliver?” was a flat no. The S&P 500 trounced almost everything outside U.S. tech. That story has shifted. Over the past year, FIVA returned roughly 35%, compared with about 27% for SPY and 29% for the iShares MSCI EAFE Value ETF (EFV), the category benchmark. Year-to-date, FIVA is up about 7% against 5% for the S&P 500.
The macro backdrop helps explain the recent acceleration. U.S. GDP growth has whipsawed from 4.4% in Q3 2025 to 0.5% in Q4 to 2% in Q1 2026, with personal consumption stuck at 1.6%. International value tends to do well when U.S. exceptionalism gets questioned and the dollar weakens.
Real users are noticing. One Reddit poster on r/RothIRA wrote that “FIVA is crushing my other two (US) funds over the past year and half or so.” Another r/ETFs investor described using FIVA as the international large-cap sleeve in a Rollover IRA. The fund tends to attract patient allocators rather than tactical traders, which fits the strategy.
The Tradeoffs You Should Know
- The value factor can underperform for years. From 2018 through roughly 2022, owning international value meant watching the S&P 500 sprint ahead. If U.S. growth resumes leadership, FIVA will lag. You need a multi-year horizon for the valuation gap thesis to play out.
- Currency risk is unhedged. FIVA’s returns include moves in the yen, euro, pound, and Canadian dollar against the U.S. dollar. The recent trade deficit averaging around $58 billion monthly has been a tailwind for foreign currencies, but the wind can shift.
- Sector composition skews cyclical. Value screens overweight financials, energy, materials, and industrials. In a sharp global slowdown, those holdings get hit harder than U.S. mega-cap tech.
FIVA fits best as a 10-20% portfolio sleeve for investors who already own broad U.S. equity exposure and want a cheap, rules-based way to lean into the international valuation discount, with the understanding that the payoff requires patience and a tolerance for cyclical drawdowns.
Top Gaining Stocks
Top Losing Stocks